Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Vitamin D in amyotrophic lateral sclerosis.
Libonati L, Onesti E, Gori MC, Ceccanti M, Cambieri C, Fabbri A, Frasca V, Inghilleri M. Libonati L, et al. Funct Neurol. 2017 Jan/Mar;32(1):35-40. doi: 10.11138/fneur/2017.32.1.035. Funct Neurol. 2017. PMID: 28380322 Free PMC article.
Chronic inflammatory demyelinating polyneuropathy: evaluation of the vestibular system with cervical and ocular vestibular evoked myogenic potentials.
Magliulo G, Iannella G, Manno A, Libonati L, Onesti E, Vestri A, Fegatelli DA, Angeletti D, Pace A, Gulotta G, Gagliardi S, Inghilleri M. Magliulo G, et al. Among authors: libonati l. Eur Arch Otorhinolaryngol. 2018 Jun;275(6):1507-1512. doi: 10.1007/s00405-018-4981-9. Epub 2018 Apr 27. Eur Arch Otorhinolaryngol. 2018. PMID: 29700616
Short-Term Ultramicronized Palmitoylethanolamide Therapy in Patients with Myasthenia Gravis: a Pilot Study to Possible Future Implications of Treatment.
Onesti E, Frasca V, Ceccanti M, Tartaglia G, Gori MC, Cambieri C, Libonati L, Palma E, Inghilleri M. Onesti E, et al. Among authors: libonati l. CNS Neurol Disord Drug Targets. 2019;18(3):232-238. doi: 10.2174/1871527318666190131121827. CNS Neurol Disord Drug Targets. 2019. PMID: 30706796 Clinical Trial.
A case of motor neuron involvement in Gaucher disease.
Pozzilli V, Giona F, Ceccanti M, Cambieri C, Frasca V, Onesti E, Libonati L, Di Bari S, Fiorini I, Cardarelli L, Santopietro M, Inghilleri M. Pozzilli V, et al. Among authors: libonati l. Mol Genet Metab Rep. 2019 Nov 12;21:100540. doi: 10.1016/j.ymgmr.2019.100540. eCollection 2019 Dec. Mol Genet Metab Rep. 2019. PMID: 31844629 Free PMC article.
Creatine Kinase and Progression Rate in Amyotrophic Lateral Sclerosis.
Ceccanti M, Pozzilli V, Cambieri C, Libonati L, Onesti E, Frasca V, Fiorini I, Petrucci A, Garibaldi M, Palma E, Bendotti C, Fabbrizio P, Trolese MC, Nardo G, Inghilleri M. Ceccanti M, et al. Among authors: libonati l. Cells. 2020 May 8;9(5):1174. doi: 10.3390/cells9051174. Cells. 2020. PMID: 32397320 Free PMC article.
Validation of the DYALS (dysphagia in amyotrophic lateral sclerosis) questionnaire for the evaluation of dysphagia in ALS patients.
Diamanti L, Borrelli P, Dubbioso R, Capasso M, Morelli C, Lunetta C, Petrucci A, Mora G, Volanti P, Inghilleri M, Tremolizzo L, Mandrioli J, Mazzini L, Vedovello M, Siciliano G, Filosto M, Matà S, Montomoli C; DYALS Study Group. Diamanti L, et al. Neurol Sci. 2022 May;43(5):3195-3200. doi: 10.1007/s10072-021-05775-1. Epub 2021 Dec 1. Neurol Sci. 2022. PMID: 34853898
23 results